Perindopril Tert-Butylamine

6 trials 3 recruiting CCardiology

Filter these 6 trials by condition, phase, country and more.

Open in Search →

6 Registered trials

3 Recruiting

2 Completed trials

6 Sponsors

12 Countries

Phase III

Phase II

Phase III/IV

Phase IV

Phase III: 1 Phase II: 1 Phase III/IV: 1 Phase IV: 3

Oversight events:

9 temporary halts 1 urgent safety measure across 1 trial

View oversight register →

Sponsors using this IMP

Andrea Di Marco 1 Assistance Publique Hopitaux De Paris 1 Medical University Of Vienna 1 Novartis Pharma AG 1 Spanish Society Of Cardiology 1 University Hospital Maastricht 1

All trials

6 total

Prevention of heart disease in heart-healthy patients with diabetes based on a special parameter (NT-proBNP) Pending

2024-519051-28-01 Phase IV 2 countries Medical University Of Vienna
Withdrawal of neurohormonal therapy in patients with non-ischemic cardiomyopathy, no late gadolinium enhancement, and negative genetic testi… Recruiting

2025-521780-12-00 Phase III/IV 1 country Andrea Di Marco
Beta-blOckers discoNtinuation in patients presenting heart FaIlure with REcovered left ventricular ejection fraction Recruiting

2023-508798-94-00 Phase III 1 country Assistance Publique Hopitaux De Paris
TREASURE trial Recruiting

2022-503135-33-00 Phase IV 1 country University Hospital Maastricht
Randomized clinical trial assessing the value of Beta-Blockers and Antiplatelet Agents in patients with Spontaneous Coronary Artery Dissecti… Ended

2024-516039-28-00 Phase IV 1 country Spanish Society Of Cardiology
A proof of concept and dose-finding study of XXB750 in patients with heart failure Ended

2023-504678-39-00 Phase II 11 countries Novartis Pharma AG

Showing 1–6 of 6 trials

← All drugs A–Z